New insider activity at AbbVie ( (ABBV) ) has taken place on March 1, 2025.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Kevin K Buckbee, the Senior Vice President and Controller at AbbVie, has recently sold 18,944 shares of the company’s stock. This significant transaction is valued at $3,853,372.
More about AbbVie
YTD Price Performance: 16.46%
Average Trading Volume: 5,782,962
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $361.9B